In no way am I as proficient in NWBOs business during the years or managements reigns.
But could Kevin Duffys short term engagement (also) have been a way to encounter the challenges they knew they were gonna meet after phase III with the FDA?
If we go with the hypothesis that Merck has been into NWBO and has an interest in DC-vax to succeed, could Duffys engagement have involved “lessons learned” from Mercks own pIII trials in order for NWBO not to “f... it up”?